Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

“U Share” Cuts Mail Order Prices For Pfizer Drugs: Medicare Discount Update

This article was originally published in The Pink Sheet Daily

Executive Summary

Prices for most other Medicare-endorsed drug discount cards remain stable in the May 24 pricing update. An exception is Omnicare subsidiary PBM Plus, which dropped retail prices $2.25 on many brands, giving it the best price on Crestor and some other products.

You may also be interested in...



Medco Expects Medicare Discount Card Program To Continue Past 2006

"I'll be surprised" if the card program is shut down on schedule, Medco CEO tells analysts. Any extension is good for Medco, he says. PBM is passing on all brand rebates under Medicare card; profits come from enrollment fees and generics.

Medco Expects Medicare Discount Card Program To Continue Past 2006

"I'll be surprised" if the card program is shut down on schedule, Medco CEO tells analysts. Any extension is good for Medco, he says. PBM is passing on all brand rebates under Medicare card; profits come from enrollment fees and generics.

U Share Card Has Best Prices On Pfizer, Lilly Brands In Latest Medicare Data

The "U Share" Medicare-endorsed discount card is offering the lowest prices on most Pfizer and Lilly prescription drug brands, according to updated pricing data posted on the Centers for Medicare & Medicaid Services website May 17

Topics

UsernamePublicRestriction

Register

PS059505

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel